Amarin Corp Plc (AMRN)

[ziploc_1]

duke... QUOTE... "I argue that the only meds that should require a PA is skinny label medications to keep them in their lane of use."...I agree with this concept.

When a product has a valid patented indication plus another non patented indication(i.e. a 'skinny label"), it should have, after the name of the med in the insurance company formulary, the initials O.C.(for other condition) so the insurance companies could recognize it as a "skinny label" and ask for a Prior Approval from the Doc(to make sure that it it is not being used in a manner,which infringes on the patented indication.

An example would be an insurance company formulary listing of BOTH Vascepa plus Icosapentethyl O.C...with the latter unpatented med needing a prior authorization for the prescription to be covered....Otherwise, the current situation of insurance companies' constantly violating patent laws, and claiming ignorance, will continue.